Saturday, May 16, 2020 7:56:08 PM
Now let’s go to present day…WTH is taking so long?! I agree with TIAB…what happened to April? That line that “we had to wait until the BP drugs got the first look” is BS! There are many microcap stocks that are far ahead us (CYDY, MESO, CAPR). Even my dog’s heart worm med is being studied. The delay is baffling. Is it a conspiracy? Or is it Leo or his reputation?
Let’s take MESO’s April for one example:
3/10: The Company is in “active discussions” (sound familiar?) with various government and regulatory authorities, medical institutions and pharmacological companies to evaluate” is product candidate in patients w/ARDS caused by Covid-19.
4/6: FDA approves IND for Compassionate Use and P2/3 trial
4/8: P2 trial announced
4/24: Report out on Compassionate Use
4/30: Begin P2/3 enrollment in 20 site, USA trial enrolling 300 patients
5/6: 1st patient dosed
5/13: Raised $90 mil to ramp up manufacturing
However, I do disagree with TIAB on B for CV. I think he’s putting too much emphasis on Leo’s track record and not focusing on the scientific strengths of B. I think we are beyond the point of Leo’s carnival barking or incompetence. B beat the best antibiotic on the market, with a one-and-done (this is now of value). This confirmed its cell wall piercing MOA. RBL 1 shows a 60% knock down of the virus. It has pieced bacteria walls in human, the CV wall in monkeys…piercing the CV wall in humans is not a stretch.
The before and after pictures of the UP trial show B’s anti-inflammatory capability. Though not “proven”, genuine potential of this MOA is confirmed by AS. It’s the cytokine storm that is killing people. If B does to epithelial lung tissue, what it did to epithelial colon tissue…???
Finally, in the 1918 pandemic, most people died from the secondary complication of pneumonia. If B was safe and hugely successful in ABSSSI, is pneumonia a stretch? It’s as if B was meant for this crisis.
If and when B does succeed, I will let my family and friends think I was a genius, and you can think that of Leo, but I will consider myself lucky, and thankful that I was part of helping humanity through it’s most trying time in modern history. And wise for doubling my position during the Covid crisis.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM